Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.21.2
Consolidated Statements of Operations - USD ($)
12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Income Statement [Abstract]    
Revenue
Expenses:    
Research and development 34,097,641 25,096,817
General and administrative 14,282,417 18,312,268
Loss from operations (48,380,058) (43,409,085)
Gain on extinguishment of debt 960,790
Other (loss) income, net (704) 185,052
Interest expense (15,857) (5,114)
Foreign currency exchange gain (loss), net (144,085) 103,136
Loss before income taxes (47,579,914) (43,126,011)
Income tax benefit (2,412,183) (872,585)
Net loss $ (45,167,731) $ (42,253,426)
Basic and diluted net loss per common share $ (1.37) $ (2.56)
Weighted average shares used in computing basic and diluted net loss per common share 32,903,366 16,534,551